• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痘苗病毒:一种适用于重组疫苗的载体?

Vaccinia virus: a suitable vehicle for recombinant vaccines?

作者信息

Kaplan C

机构信息

Department of Microbiology, University of Reading, England.

出版信息

Arch Virol. 1989;106(1-2):127-39. doi: 10.1007/BF01311044.

DOI:10.1007/BF01311044
PMID:2669685
Abstract

The complications of vaccination against small pox are discussed in relation to the contemplated use as vaccines of recombinant vaccinia viruses carrying the genes for "protective" antigens derived from a range of pathogens. Recombinant vaccines are potentially extremely valuable instruments in the fight against infectious diseases, but caution is needed in their deployment. In addition to the dangers associated with the pathogenicity of various strains of vaccinia virus, there may be problems related to the ecology of the poxviruses--especially orthopoxviruses. Before recombinant vaccinia virus vaccines are widely used, ecological research is urgently needed. It should cover not only the ecology of orthopoxviruses, but also possible interactions between engineered vaccinia viruses released into the environment and wild viruses which may be resident in both target and non-target species in a wide selection of habitats.

摘要

本文讨论了天花疫苗接种的并发症,这些并发症与使用携带多种病原体“保护性”抗原基因的重组痘苗病毒作为疫苗的设想用途相关。重组疫苗在对抗传染病方面可能是极具价值的工具,但在其应用中需要谨慎。除了与各种痘苗病毒株致病性相关的危险外,还可能存在与痘病毒生态学相关的问题,尤其是正痘病毒。在重组痘苗病毒疫苗广泛使用之前,迫切需要进行生态学研究。该研究不仅应涵盖正痘病毒的生态学,还应包括释放到环境中的工程痘苗病毒与可能存在于广泛栖息地的目标和非目标物种中的野生病毒之间的可能相互作用。

相似文献

1
Vaccinia virus: a suitable vehicle for recombinant vaccines?痘苗病毒:一种适用于重组疫苗的载体?
Arch Virol. 1989;106(1-2):127-39. doi: 10.1007/BF01311044.
2
Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.痘病毒作为真核克隆和表达载体:未来的医学和兽用疫苗
Prog Vet Microbiol Immunol. 1988;4:197-217.
3
Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.E3L基因发生突变的痘苗病毒作为具有潜在复制能力的减毒疫苗:鼻内接种。
Vaccine. 2008 Jan 30;26(5):664-76. doi: 10.1016/j.vaccine.2007.11.045. Epub 2007 Dec 4.
4
Clinical development of Modified Vaccinia virus Ankara vaccines.安卡拉痘苗病毒改良疫苗的临床研发。
Vaccine. 2013 Sep 6;31(39):4241-6. doi: 10.1016/j.vaccine.2013.03.020. Epub 2013 Mar 21.
5
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.用于重组基因表达、疫苗接种和安全性的基因工程痘病毒。
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11341-8. doi: 10.1073/pnas.93.21.11341.
6
Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.基于第三代天花疫苗株的重组疫苗用于病毒性出血热。
Vaccine. 2021 Oct 1;39(41):6174-6181. doi: 10.1016/j.vaccine.2021.09.001. Epub 2021 Sep 11.
7
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies.在临床前研究中,改良安卡拉牛痘病毒的保护效力。
Vaccine. 2013 Sep 6;31(39):4235-40. doi: 10.1016/j.vaccine.2013.03.016. Epub 2013 Mar 21.
8
Poxviruses as vaccine vectors.痘病毒作为疫苗载体。
Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):343-55. doi: 10.1016/S0147-9571(03)00019-5.
9
Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.巴西历史上的天花疫苗株IOC的基因组分析、表型及毒力:对痘苗病毒起源和进化关系的启示
J Virol. 2015 Dec;89(23):11909-25. doi: 10.1128/JVI.01833-15. Epub 2015 Sep 16.
10
Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice.重组痘苗病毒在痘苗免疫小鼠中的保护效力
Immunol Cell Biol. 1989 Oct;67 ( Pt 5):339-41. doi: 10.1038/icb.1989.49.

引用本文的文献

1
Monkeypox: An Emerging Global Public Health Emergency.猴痘:一场新出现的全球公共卫生突发事件。
Life (Basel). 2022 Oct 12;12(10):1590. doi: 10.3390/life12101590.
2
Vaccination strategies to combat novel corona virus SARS-CoV-2.应对新型冠状病毒 SARS-CoV-2 的疫苗接种策略。
Life Sci. 2020 Sep 1;256:117956. doi: 10.1016/j.lfs.2020.117956. Epub 2020 Jun 12.
3
Replicating poxviruses for human cancer therapy.用于人类癌症治疗的痘病毒复制

本文引用的文献

1
AMOUNT AND DURATION OF IMMUNITY INDUCED BY INTRADERMAL INOCULATION OF CULTURED VACCINE VIRUS.皮内接种培养疫苗病毒诱导的免疫的数量和持续时间。
J Exp Med. 1939 May 31;69(6):857-66. doi: 10.1084/jem.69.6.857.
2
FURTHER OBSERVATIONS ON THE CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.人类詹纳氏预防接种用疫苗病毒的进一步培养观察。
J Exp Med. 1933 Oct 31;58(5):635-50. doi: 10.1084/jem.58.5.635.
3
CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.人类詹纳氏预防接种用疫苗病毒的培养。
J Microbiol. 2015 Apr;53(4):209-18. doi: 10.1007/s12275-015-5041-4. Epub 2015 Apr 8.
4
Lineage specific antigenic differences in porcine torovirus hemagglutinin-esterase (PToV-HE) protein.猪传染性胃肠炎病毒血凝素-神经氨酸酶(PToV-HE)蛋白的谱系特异性抗原差异。
Vet Res. 2013 Dec 23;44(1):126. doi: 10.1186/1297-9716-44-126.
5
Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.利用表达干扰素 γ 的重组痘苗病毒进行暴露后预防天花和兔热病病毒感染。
PLoS One. 2013 Oct 17;8(10):e77879. doi: 10.1371/journal.pone.0077879. eCollection 2013.
6
The infectious bursal disease virus RNA-binding VP3 polypeptide inhibits PKR-mediated apoptosis.传染性腔上囊病病毒 RNA 结合 VP3 多肽抑制 PKR 介导的细胞凋亡。
PLoS One. 2012;7(10):e46768. doi: 10.1371/journal.pone.0046768. Epub 2012 Oct 9.
7
The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response.痘苗病毒 E3 蛋白的氨基末端对于抑制干扰素反应是必需的。
J Virol. 2012 May;86(10):5895-904. doi: 10.1128/JVI.06889-11. Epub 2012 Mar 14.
8
Oncolytic vaccinia virus: a silver bullet?溶瘤痘苗病毒:万灵药?
Expert Rev Vaccines. 2010 Dec;9(12):1353-6. doi: 10.1586/erv.10.137.
9
Post-vaccination dermatolipomyonecrosis.疫苗接种后皮肤脂肪坏死
Wien Klin Wochenschr. 2009;121(17-18):551. doi: 10.1007/s00508-009-1245-0.
10
Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.E3L基因发生突变的痘苗病毒作为具有潜在复制能力的减毒疫苗:鼻内接种。
Vaccine. 2008 Jan 30;26(5):664-76. doi: 10.1016/j.vaccine.2007.11.045. Epub 2007 Dec 4.
J Exp Med. 1931 Sep 30;54(4):453-61. doi: 10.1084/jem.54.4.453.
4
Titration of vaccinia virus by intravenous injection of chick embryos.通过静脉注射鸡胚对痘苗病毒进行滴定
Bull World Health Organ. 1960;22(3-4):393-7.
5
The development of a stable smallpox vaccine.一种稳定的天花疫苗的研发。
J Hyg (Lond). 1955 Mar;53(1):76-101. doi: 10.1017/s002217240000053x.
6
ILLNESSES ATTRIBUTED TO SMALLPOX VACCINATION, 1951-60. II. ILLNESSES REPORTED AS AFFECTING THE CENTRAL NERVOUS SYSTEM.1951 - 1960年因天花接种导致的疾病。二、报告影响中枢神经系统的疾病
Mon Bull Minist Health Public Health Lab Serv. 1964 Sep;23:150-60.
7
ILLNESS ATTRIBUTED TO SMALLPOX VACCINATION DURING 1951-60.1951年至1960年期间归因于天花疫苗接种的疾病。
Mon Bull Minist Health Public Health Lab Serv. 1964 Aug;23:126-33 CONTD.
8
CUTANEOUS COMPLICATIONS OF MASS VACCINATION AGAINST SMALLPOX IN SOUTH WALES 1962.1962年南威尔士大规模天花疫苗接种的皮肤并发症
Trans St Johns Hosp Dermatol Soc. 1964;50:22-42.
9
HYBRIDS DERIVED FROM THE VIRUSES OF ALASTRIM AND RABBIT POX.源自类天花病毒和兔痘病毒的杂种病毒。
J Hyg (Lond). 1964 Jun;62(2):141-6. doi: 10.1017/s0022172400039875.
10
THE USE OF CEILING TEMPERATURE AND REACTIVATION IN THE ISOLATION OF POX VIRUS HYBRIDS.天花病毒杂种分离中最高温度及再活化的应用
J Hyg (Lond). 1964 Jun;62(2):133-40. doi: 10.1017/s0022172400039863.